Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer

World Journal of Gastroenterology

Volumn 11, Issue 21, 2005, Pages 3245-3249

  Salminen, Eeva ^a   Palmu, Salla ^a   Vahlberg, Tero ^b   Roberts, Peter J ^a   Söderström, Karl Owe ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Grade; Ki67; Proliferative activity; Rectal cancer; Stage

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR LOCALIZATION;

EID: 22144443169     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i21.3245     Document Type: Article

References (23)

1. WHO: The World Health Report. Geneva, World Health Organization, 1997
2. Kapitejn E, Liefers GJ, Los LC, Kranenberg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH. Mechanism of oncogenesis in colon versus rectal cancer. J Pathol 2001; 195: 171-178
3. Isola JJ, Helin HJ, Helle MJ, Kallioniemi OP. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis and mitotic count. Cancer 1990; 65: 1180-1184
4. Garrido MC, Cordell JL, Becker MH, Key G, Gerdes J, Jones M, Gatter KC, Mason DY. Monoclonal antibody JC1: new reagent for studying cell proliferation. J Clin Pathol 1992; 45: 860-865
5. Kirla R, Salminen EK, Huhtala S, Nuutinen JM, Talve L, Haapasalo H, Kalimo H. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and pRb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. J Neuro Oncol 2000; 46: 71-80
6. Pollack A, DeSilvio M, Khor LY, Li R, Al-Saleem TI, Hammond ME, Venkatesan V, Lawron CA, Roach M 3rd, Shipley WU, Hanks GE, Sandler HM. Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy and androgen deprivation: Radiation Therapy Oncology Group Trial 92-02. J Clin Oncol 2004; 22: 2133-2140
7. Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stenbridge EJ, Palotie A, Figlin RA, Belldegrun AS. Prognostic value of kroniek anhydrase IX and Ki67 as predictor of survival for renal clear cell cancer. J Urol 2004; 171: 2461-2466
8. Tisell LE, Oden A, Muth A, Altiparmak G, Molne J, Ahlman H, Nilsson O. The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer 2003; 89: 2093-2097
9. Palmqvist R, Sellberg P, Öberg Å, Tavelin B, Rutegård J, Stenling R. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Duke's stage B colorectal cancer. Br J Cancer 1999; 79: 577-581
10. Willett CG, Warland G, Hagan MP, Dasly WJ, Coen J, Shellito PC, Compton CC. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995; 13: 1417-1424
11. Kimura T, Tanaka S, Haruma K, Sumii K, Kajiyama G, Shimamoto F, Kohno N. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer. Int J Oncol 2000; 16: 55-64
12. UICC International Union Against cancer: TNM Classification of malignant tumours.5th edition, WHO, Geneva, 1997
13. Beahrs OH. Colorectal cancer staging as a prognostic feature. Cancer 1982; 50(11 Suppl): 2615-2617
14. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214
15. Kockerling F, Reymond M, Altendorf-Hoffman A, Dworak O, Hohenberger W. Influence of surgery onmetachronous distant metastases and survival in rectal cancer. J Clin Oncol 1988; 16: 324-329
16. Pahlman L. Rectal carcinoma, type of surgery and the role of adjuvant radiation therapy. Ann Chir Gynaecol 1993; 82: 153-158
17. Lehy T, Abithol JL, Mignon M. Influence de la preparathion rectale par lavement sur la proliferation cellulaire dans la muceuse rectale normale de l'homme. Gastroenterol Clin Biol 1984; 8: 216-221
18. Jansson A, Sun XF. Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinoma. APMIS 1997; 105: 730-734
19. van Oijen MG, Medema RH, Slootweg PJ, Rijksen G. Positivity of the proliferation marker Ki-67 in noncykling cells. Am J Clin Pathol 1998; 110: 24-31
20. Duchrow M, Ziemann T, Windhövel U, Bruch HP, Broll R. Colorectal carcinomas with high MIB-1 labelling indices but low pKi67 mRNA levels correlate with better prognostic outcome. Histopathology 2003; 42: 566-574
21. Porschen R, Lohe B, Hengels KJ, Borchard F. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67. Correlation with pathohistologic criteria and influence of irradiation. Cancer 1989; 64: 2501-2505
22. Reerink O, Karrenbeld A, Plukker J, Verschuren R, Szabo B, Slutter W, Hospers G, Mulder N. Molecular prognostic factors in locally inresectable rectal cancer treated preoperatively by chemo-radiotherapy. Anticancer Res 2004; 24: 1217-1222
23. Fernebro E, Brendahl PO, Dictor M, Persson A, Fernö M, Nilvbert M. Immunohistochemical patterns in rectal cancer: application of tissue microarrays with prognostic correlations. Int J Cancer 2004; 111: 921-828